Global IT services provider FPT has been named a Frontier Partner by Microsoft, becoming the first Microsoft Enterprise System Integrator (ESI) partner in Southeast Asia to receive this designation. The recognition underscores FPT's deep expertise in enterprise AI and cloud solutions, and reflects the strategic partnership both companies have built to drive AI-first transformation for enterprises worldwide. This press release features multimedia. View the full release here: https://www.busines...

From May 16 to 20, the 2026 ASC Student Supercomputer Challenge (ASC26) Grand Finals will be held at Wuxi University, bringing together 25 finalist teams selected from more than 300 participating universities worldwide. During the on-site competition, teams will independently design and deploy small-scale supercomputing clusters under a strict 5000W power constraint. They will complete a range of advanced computing challenges and deliver presentations showcasing their technical achievements and...

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional s...

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal r...